Early research (Phase 1)Study completedNCT00422825What this trial is testingEffect of Food on Bioavailability of a Modified Release Formulation of ImatinibWho this might be right forHealthy Novartis Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT00110955What this trial is testingTreatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyWho this might be right forAnemiaNon-Myeloid Malignancies Amgen 391
Not applicableNot Yet RecruitingNCT05602168What this trial is testingCollection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment ResistanceWho this might be right forHematologic Cancer Institut Paoli-Calmettes 400
Early research (Phase 1)Study completedNCT02782468What this trial is testingPevonedistat in Adult East Asian ParticipantsWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Millennium Pharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT03418038What this trial is testingAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaWho this might be right forClonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more Mayo Clinic 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06854276What this trial is testingStudy of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid MalignanciesWho this might be right forChemotherapy-induced AnemiaNon-myeloid Malignancies Shenyang Sunshine Pharmaceutical Co., LTD. 80
Testing effectiveness (Phase 2)Study completedNCT00129740What this trial is testingPhase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)Who this might be right forLeukemia, Myelogenous, Chronic M.D. Anderson Cancer Center 148
Testing effectiveness (Phase 2)Study completedNCT00118326What this trial is testingDonor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseWho this might be right forKidney CancerLeukemiaLymphoma+3 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00125840What this trial is testingClofarabine in Adult Patients With Advanced Solid TumorsWho this might be right forSolid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more Genzyme, a Sanofi Company
Large-scale testing (Phase 3)Study completedNCT01511289What this trial is testingRadotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase PatientsWho this might be right forLeukemiaLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL Positive+3 more Il-Yang Pharm. Co., Ltd. 242
Testing effectiveness (Phase 2)Study completedNCT02092324What this trial is testingRuxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid LeukemiaWho this might be right forAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Neutrophilic Leukemia OHSU Knight Cancer Institute 51
Testing effectiveness (Phase 2)Study completedNCT00072579What this trial is testingSargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial TreatmentWho this might be right forLeukemia Wake Forest University Health Sciences
Large-scale testing (Phase 3)Looking for participantsNCT04168502What this trial is testingGemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AMLWho this might be right forAcute Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 414
Post-approval studies (Phase 4)Study completedNCT00180102What this trial is testingAML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 YearsWho this might be right forLeukemia, Nonlymphocytic, Acute Technische Universität Dresden 600
Large-scale testing (Phase 3)Looking for participantsNCT07583888What this trial is testingVABu Conditioning in Elderly AML HSCTWho this might be right forAllogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML) The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Ended earlyNCT02096042What this trial is testingPhase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)Who this might be right forLeukemia M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06696183What this trial is testingGilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive TreatmentWho this might be right forAML - Acute Myeloid Leukemia Technische Universität Dresden 60
Large-scale testing (Phase 3)UnknownNCT00025402What this trial is testingChemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia III. Medizinische Klinik Mannheim 1,000
Testing effectiveness (Phase 2)Study completedNCT00739141What this trial is testingConditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.Who this might be right forLeukemiaMyelodysplastic SyndromeNon-Hodgkins Lymphoma+2 more Memorial Sloan Kettering Cancer Center 86
Not applicableWithdrawnNCT06362031What this trial is testingExplore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart ReviewWho this might be right forAcute Myeloid Leukemia AbbVie